Shire Opts Not To Sue Teva Over Adderall XR ANDA
In February, Shire said that it had received a Paragraph IV Notice letter from Teva advising of the filing of an Abbreviated New Drug Application for its amphetamine combination product, a generic version of Shire's Adderall XR, a mixed amphetamine salts product.
Shire has filed lawsuits against generics makers Barr Laboratories and Impax, the first two...
Already a subscriber? Click here to login